StockCIK 1818382

Humacyte, Inc. (HUMA): Insider Trades and Fund Holdings

In the past 12 months, Humacyte, Inc. insiders reported 3 open-market purchases worth $30K and 0 sales worth $0.

3Insider buys, 12 months

$30KBought by insiders, 12 months

$0Sold by insiders, 12 months

0Tracked funds holding

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Sep 15, 2026.

Recent HUMA insider trades
Filed	Traded	Insider	Role	Type	Shares	Price ($)	Value	Holding	Filing
Sep 15	Sep 14	Keith Anthony JonesDirector	Director	▲ BUY	10,000	0.562	$6K	+25%	Form 4 ↗
Aug 21	Aug 20	Keith Anthony JonesDirector	Director	▲ BUY	10,000	0.693	$7K	+33%	Form 4 ↗
Aug 19	Aug 17	Keith Anthony JonesDirector	Director	▲ BUY	30,000	0.594	$18K	New	Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Insiders who traded in the past year

Insider	Role	Buys	Bought	Sells	Sold	Latest
Keith Anthony Jones	Director	3	$30K	0	$0	Sep 15, 2026

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →